Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Share-based Compensation: 2010-2025

Historic Share-based Compensation for Neogen (NEOG) over the last 15 years, with Aug 2025 value amounting to $5.0 million.

  • Neogen's Share-based Compensation rose 24.61% to $5.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $18.3 million, marking a year-over-year increase of 20.90%. This contributed to the annual value of $17.3 million for FY2025, which is 25.59% up from last year.
  • According to the latest figures from Q3 2025, Neogen's Share-based Compensation is $5.0 million, which was up 14.60% from $4.3 million recorded in Q2 2025.
  • Neogen's 5-year Share-based Compensation high stood at $5.0 million for Q3 2025, and its period low was $1.6 million during Q1 2021.
  • Moreover, its 3-year median value for Share-based Compensation was $3.9 million (2024), whereas its average is $3.8 million.
  • In the last 5 years, Neogen's Share-based Compensation dropped by 3.60% in 2021 and then spiked by 74.98% in 2023.
  • Neogen's Share-based Compensation (Quarterly) stood at $1.7 million in 2021, then skyrocketed by 50.57% to $2.6 million in 2022, then surged by 33.43% to $3.5 million in 2023, then spiked by 37.22% to $4.8 million in 2024, then increased by 24.61% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $4.3 million for Q2 2025, and $4.2 million during Q1 2025.